SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Capital.com Receives Approval for Singapore Capital Markets Licence

Capital.com received approval for a capital markets licence in Singapore.

SquawkNews Desk 1 updates Updated Nov 02, 2026, 11:55 AM UTC

Story updates

11:55:00 AM UTC
SquawkNews
By Gregor Stuart HunterCapital.com said on Monday it has received approval for a securities licence from the Monetary Authority of Singapore, according to a regulatory filing.

Related stories

Hangzhou SDIC Microelectronics and Controlling Shareholder Probed by Regulator The company says it and its controlling shareholder are under investigation over suspected information disclosure violations. L impact | REGULATION | Nov 02, 2026, 01:41 PM UTC FDA Places Bright Minds Biosciences Seizure Drug Application on Partial Hold Bright Minds Biosciences said the FDA placed its drug application and planned trial for a seizure treatment on partial clinical hold following a review. The stock fell 36% to $35 i M impact | REGULATION | Nov 02, 2026, 01:19 PM UTC NRx Pharmaceuticals Receives FDA Approval for Preservative-Free Ketamine NRx Pharmaceuticals said the FDA approved its preservative-free ketamine application ahead of the agency’s November 10 goal date. M impact | REGULATION | Nov 02, 2026, 01:13 PM UTC UniQure Says FDA Accepts Application for Huntington’s Gene Therapy UniQure said the FDA accepted an application for its potential Huntington’s disease gene therapy. L impact | REGULATION | Nov 02, 2026, 01:06 PM UTC Catheter Precision Announces FDA 510(k) Clearance for VIVO System The clearance enables use of the VIVO system in a broader patient population. L impact | REGULATION | Nov 02, 2026, 01:05 PM UTC Lupin Receives U.S. FDA Approval for Amifampridine Tablets M impact | REGULATION | Nov 02, 2026, 12:34 PM UTC